Mild Cognitive Impairment
Cognitive decline beyond normal ageing — but not dementia
What it is
Mild cognitive impairment is measurable decline in memory or thinking that is greater than expected for age but does not yet significantly impair daily independence. It is a risk state: some people progress to dementia, some remain stable, and some improve — particularly when a reversible cause is found.
Why it matters
MCI is the highest-leverage window in cognitive medicine. It is the point at which reversible causes can still be found and corrected, vascular risk can be aggressively treated, and — where appropriate — early disease-modifying therapy can be considered. Not everyone with MCI progresses.
What BioSignal knows about treating this
What works for Mild Cognitive Impairment
BioSignal’s clinical summary, most important first.
- Find and treat reversible causes (B12, thyroid, depression, medications, sleep apnoea)
- Aggressive vascular risk-factor control
- Physical activity (best-supported behaviour)
- Multidomain lifestyle intervention (FINGER-style)
- Hearing correction and cognitive/social engagement
Signal Records relevant to this condition
Interventions and contributing factors — some of these records describe a cause rather than a cure. The rating shown is BioSignal’s confidence in that Signal Record, not a claim about how well it treats this condition. Open any of them for the full evidence.
- Citicoline (CDP-Choline)Limited evidence
The best-evidenced popular nootropic, but mixed — a modest signal in vascular cognitive impairment, weak evidence in healthy adults, no dementia prevention.
- Omega-3 Fatty AcidsModerate confidence
Lowers triglycerides, and reduces preterm birth in pregnancy. Routine fish oil does NOT prevent cardiovascular disease, cancer or dementia in the general population. High-dose omega-3 increases atrial fibrillation risk — a real harm most bottles do not mention.
New to this? Read these first
How this usually unfolds
- Recognize risk factors
- Get diagnosed
- Track key biomarkers
- Lifestyle first
- Evidence-based treatment
- Long-term monitoring
Who is at risk
- Older age
- Vascular risk factors (hypertension, diabetes, high ApoB)
- APOE4
- Depression
- Hearing loss
- Physical inactivity
- Poor sleep / sleep apnoea
How it's diagnosed
Diagnosed by objective cognitive testing showing impairment with preserved independence, alongside careful exclusion of reversible contributors — B12 deficiency, thyroid disease, depression, medication effects, alcohol, and sleep apnoea.
Key biomarkers
Lifestyle
Explore this condition across BioSignal
Related Foundations
Related Signal Records
Related body systems
Frequently asked questions
Does mild cognitive impairment always become dementia?
No. Some people progress, many remain stable, and some improve — especially when a reversible cause (like B12 deficiency, depression, medication effects, or sleep apnoea) is found and corrected. That's why evaluation matters.
What should I do first if I have MCI?
Get the reversible causes excluded (B12, thyroid, depression, medications, sleep apnoea), then treat vascular risk aggressively and get moving. Those are the highest-yield steps — far more than any supplement.
Evidence summary
Reversible-cause identification is standard practice; multidomain lifestyle intervention (FINGER) and blood-pressure lowering (SPRINT MIND, which significantly reduced MCI) have randomized support. No supplement is established to prevent progression.
References & sources
- SPRINT MIND
- FINGER trial
- Lancet Commission on dementia
Educational information — not medical advice
Is this condition page clear, accurate, and useful? Your feedback shapes what we review next.
Give feedback